|
Metabolic outcome b
|
DM use
|
Italy
|
Estonia
|
Cyprus
|
Belgium
|
Sweden
|
Germany
|
Hungary
|
Spain
|
|---|
| |
Mean intercept (h/day)
|
2.0258
|
2.3790
|
2.1022
|
1.7932
|
2.0210
|
1.6706
|
1.7521
|
1.5931
|
| |
Mean slope (h/day/year)
|
0.1144
|
0.1785
|
0.1583
|
0.1483
|
0.1746
|
0.1493
|
0.1298
|
0.1012
|
| | |
Adjusted odds ratios (OR) and 95% confidence intervals (95% CI)
|
|
Abdominal obesity
|
Slope c
|
0.90 (0.68–1.20)
|
1.21 (0.86-1.70)
|
1.03 (0.75–1.41)
|
0.74 (0.46–1.20)
|
1.69 (1.05–3.23)
|
0.93 (0.63–1.36)
|
1.31 (0.90–1.92)
|
0.99 (0.67–1.46)
|
|
Intercept
|
1.28 (0.96–1.69)
|
1.62 (1.17–2.23)
|
1.53 (1.11–2.09)
|
2.07 (1.21–3.54)
|
1.84 (1.05–3.23)
|
1.78 (1.24–2.57)
|
1.13 (0.75–1.73)
|
2.11 (1.32–2.38)
|
|
Elevated BP d
|
Slope
|
1.28 (0.94–1.74)
|
0.98 (0.68–1.41)
|
1.12 (0.73–1.70)
|
1.87 (1.16–3.02)
|
0.68 (0.40–1.18)
|
0.79 (0.47–1.32)
|
1.17 (0.84–1.64)
|
0.71 (0.49–1.03)
|
|
Intercept
|
0.96 (0.72–1.28)
|
1.28 (0.90–1.81)
|
1.24 (0.83–1.85)
|
1.66 (0.99–2.80)
|
1.04 (0.52–2.07)
|
0.86 (0.50–1.47)
|
1.05 (0.73–1.50)
|
0.88 (0.55–1.41)
|
|
Dyslipidemia
|
Slope
|
0.96 (0.67–1.17)
|
1.00 (0.63–1.58)
|
1.66 (1.05–2.63)
|
0.61 (0.18–2.04)
|
1.19 (0.73–1.94)
|
0.86 (0.50–1.50)
|
0.86 (0.56–1.30)
|
0.77 (0.45–1.30)
|
|
Intercept
|
1.10 (0.80–1.52)
|
1.46 (0.94–2.28)
|
1.09 (0.69–1.73)
|
2.37 (0.52–10.8)
|
1.72 (0.92–3.19)
|
1.37 (0.80–2.33)
|
1.30 (0.83–2.03)
|
1.37 (0.75–2.52)
|
|
Insulin resistance
|
Slope
|
0.86 (0.61–1.22)
|
1.36 (0.92–2.01)
|
1.45 (0.96–2.16)
|
0.73 (0.40–1.36)
|
0.94 (0.63–1.40)
|
1.05 (0.63–1.75)
|
0.81 (0.53–1.22)
|
0.98 (0.64–1.50)
|
|
Intercept
|
0.84 (0.60–1.17)
|
1.42 (0.97–2.08)
|
1.20 (0.80–1.80)
|
1.51 (0.72–3.15)
|
1.87 (1.12–3.12)
|
1.58 (0.95–2.62)
|
1.12 (0.70–1.77)
|
0.73 (0.43–1.24)
|
|
MetS
|
Slope
|
0.99 (0.66–1.49)
|
1.69 (0.87–3.23)
|
2.66 (1.38–5.14)
|
2.08 ( 0.37–11.58)
|
1.29 (0.54–3.08)
|
0.82 (0.25–2.66)
|
1.34 (0.74–2.41)
|
0.91 (0.48–1.73)
|
|
Intercept
|
0.95 (0.66–1.38)
|
1.78 (0.97–3.24)
|
1.66 (0.94–2.83)
|
1.14 (0.14–8.86)
|
2.78 (1.04–7.41)
|
4.35 (1.68–11.29)
|
2.38 (1.33–4.25)
|
1.57 (0.76–3.25)
|
- a Models are adjusted for age (continuous) sex, pubertal status, parental ISCED, HDAS, unhealthy snack intake, observation period and abdominal obesity (when not part of the outcome). The number of participants varied across countries due to missing values for different metabolic outcomes. Bold significance is provided via confidence limits
- b The reference category for the metabolic outcomes is below the monitoring level
- c Slope was used as a categorical variable (above vs. below population mean random slope)
- d BP blood pressure, DM digital media, MetS metabolic syndrome
